Imtiaz Hussain, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 Hospital Dr, South Williamson, KY 41503 Phone: 606-237-4943 Fax: 606-237-1740 |
News Archive
An editorial published online November 20 in the Journal of the National Cancer Institute discusses the exaggerated fears and hopes that often appear in news coverage of cancer research. The editorial provides guidance for both the media and journals to help alleviate the problem.
Siemens Healthineers announced today the availability of its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.
Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.
We all know the feeling, the short, sharp shock of waking to the sound of an alarm clock. Whether the traditional clattering metal bells, the incessant beeping of digital or the dulcet tones of today's radio news reader. Even the chance to slap the snooze button to grab a few extra moments between the sheets does not leave everyone feeling refreshed when they finally crawl out of bed. Now, researchers in India think they have the answer.
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
› Verified 8 days ago